Cabinet approves National Health Policy 2017

downloadSource:, Mar 17, 2017

New Delhi: Terming the Cabinet approval of the National Health Policy 2017 as a huge milestone in the history of public health in the country, Union Minister for Health & Family Welfare Shri J P Nadda said that it seeks to reach everyone in a comprehensive integrated way to move towards wellness. Shri Nadda added that NHP 2017, which is patient-centric and quality-driven, provides the much needed policy framework for achieving universal health coverage and delivering quality health care services to all at an affordable cost. The Union Health Minister stated under the guidance of the Hon. Prime Minister Shri Narendra Modiji, the Health Ministry has formulated the National Health Policy 2017, after a gap of 14 years, to address the current and emerging challenges necessitated by the changing socio-economic and epidemiological landscapes since the last National Health Policy was framed in 2002.

Read the rest of this entry »


Government to develop six bulk drugs, medical devices parks

imagesSource: The Economic Times, Jun 05, 2016

NEW DELHI: To reduce import dependence, the government has decided to establish six bulk drug and medical devices parks, which will entail a combined investment of Rs 60,000 crore.

“The government has decided to establish 3 bulk drugs and 3 medical devices parks across the country. These parks will require an investment of about Rs 60,000 crore,” Fertiliser Minister Ananth Kumar told PTI. As per various estimates, once these parks become operational, they can bring down the cost of production of devices and bulk drugs by at least 30 per cent and in long-run, this will help the general public also, he said.

“As much as 80 per cent of our total requirement of bulk drugs/APIs and 65 per cent of total demand of medical devices is met through imports. So, we want this to be reduced by facilitating domestic manufacturing,” Kumar said.

Read the rest of this entry »

The changing pattern of healthcare in India

Source:, Apr 05, 2016

The evolution of healthcare in India over the past 25 years has been a mixed bag. While key health metrics such as the infant mortality rate (IMR) and maternal mortality ratio (MMR) have come down substantially, healthcare expenses have shot up—a direct fallout of lower public health spending. The government’s allocation to healthcare as a percentage of the country’s gross domestic product (GDP) has fallen to 1.05% in 2015-16 from 1.47% in 1986-87.

IMR has fallen to 41 per 1,000 live births in 2013 from 88 in 1990, according to a United Nations report ‘Levels and Trends in Child Mortality’ released in 2015. Similarly, according to a World Health Organization (WHO) report released in 2014, MMR in India has declined from 560 deaths per 100,000 live births in 1990 to 190 in 2013.

Read the rest of this entry »

India biggest exporter of doctors, nurses to Europe

indexSource: The Economic Times, Dec 28, 2015

LONDON: India has emerged as the largest exporter of doctors and nurses to European countries, a media report said today. More than a third of National Health Service (NHS) doctors, some 35 per cent, in the UK alone were born abroad, the Organisation for Economic Cooperation and Development (OECD) said.

“India and the Philippines were the largest exporters of doctors and nurses to OECD countries, by a ‘spectacular’ margin,” the Telegraph quoted the yet-to-be-published report as saying.

Read the rest of this entry »

Primary market gets a health care boost

indexSource: Business Standard, Dec 11, 2015

Initial Public Offers (IPOs) of equity by two entities in the burgeoning health care sector drew strong response from investors on Thursday.

Alkem Laboratories, a leading pharmaceutical company, and Dr Lal PathLabs, a prominent diagnostics chain operator, saw bids worth Rs 57,000 crore, for the less than Rs 2,000 crore on offer.

Alkem’s was Rs 1,350 crore and Dr Lal’s IPO was Rs 630 crore, at the top end of the band. Both issues were Offers for Sale from existing shareholders and didn’t involve issue of new shares.

The IPOs saw robust demand from all investor segments, in contrast with the recent marquee offerings of InterGlobe Aviation and Coffee Day Enterprises, given a miss by retail (small) investors.

Read the rest of this entry »

India risks missing boat as biosimilars shake up drug industry

 BioTechSource: Financial Express, Oct 15, 2015

Mumbai: India, which has dominated the generic drugs industry for decades, is falling behind in the race to make copies of complex biotech drugs, which are expected to generate tens of billions of dollars in sales in the coming years.

While Indian firms have launched a few such products on the domestic market, where regulatory barriers are relatively low, they are being overtaken by European, American and South Korean firms in the race to supply lucrative Western markets.

Read the rest of this entry »

India and USA sign agreements to strengthen cooperation in health sector

Business agreementsSource:, Jun 26, 2015

New Delhi: India and the United States of America (USA) signed Memorandums of Understanding (MoUs) on Cooperation on Cancer Research, Prevention, Control and Management and Collaboration in Environmental and Occupational Health and Injury Prevention and Control, and a Letter of Intent (LoI) on Antimicrobial Resistance Research, here today. The MoU on Cancer Research and LoI on Antimicrobial Resistance Research were signed by Shri B P Sharma, Secretary (Department of Health and Family Welfare and Department of Health Research), Ministry of Health and Family Welfare andProf. K Vijay Raghavan, Secretary (Department of Biotechnology), Ministry of Science & Technology and Mr. Richard Verma, Ambassador of the USA to India. While, the MoU on Collaboration in Environmental and Occupational Health and Injury Prevention and Control was signed by Shri B P Sharma and Mr. Richard Verma.

Read the rest of this entry »